ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,593Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 2456

$770K Total Retail Price of All Prescriptions

Rank: 84 out of 2456

264 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 264 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 264 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 11,971 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
TRAZODONE HCL 792 709 1 17
WARFARIN SODIUM 790 739 2 9
SIMVASTATIN 445 419 3 2
LEVOTHYROXINE SODIUM 410 388 4 4
FUROSEMIDE 399 363 5 8
METOPROLOL TARTRATE 377 338 6 10
MIRTAZAPINE 354 335 7 29
LISINOPRIL 349 302 8 1
DONEPEZIL HCL 334 330 9 23
OMEPRAZOLE 319 294 10 3
METOPROLOL SUCCINATE 311 285 11 13
DIVALPROEX SODIUM 292 234 12 51
CITALOPRAM HBR 288 267 13 14
AMLODIPINE BESYLATE 286 262 14 5
NAMENDA 257 257 15 42
QUETIAPINE FUMARATE 234 186 16 47
GABAPENTIN 187 166 17 16
ATENOLOL 175 163 18 6
RANITIDINE HCL 157 134 19 31
POTASSIUM CHLORIDE 151 132 20 33
OLANZAPINE 144 144 21 57
LIDODERM 142 140 22 58
DIGOXIN 139 138 23 49
METFORMIN HCL 126 114 24 11
VENLAFAXINE HCL ER 120 108 25 92
RISPERIDONE 116 77 26 50
SERTRALINE HCL 107 101 27 21
LANTUS 107 67 27 44
HYDROCHLOROTHIAZIDE 103 89 29 7
ALENDRONATE SODIUM 98 98 30 19
TAMSULOSIN HCL 96 94 31 32
ABILIFY 92 63 32 95
TRAMADOL HCL 91 90 33 24
ALLOPURINOL 90 89 34 27
ATORVASTATIN CALCIUM 88 71 35 12
NOVOLIN R 86 79 36 173
CARBIDOPA-LEVODOPA 84 73 37 82
HEPARIN SODIUM 83 53 38 256
ENOXAPARIN SODIUM 82 61 39 186
LEVETIRACETAM 79 59 40 90
FAMOTIDINE 72 68 41 84
CYMBALTA 72 59 41 65
SEROQUEL 70 60 43 102
LEVOFLOXACIN 69 62 44 103
CLOZAPINE 67 67 45 75
TOPIRAMATE 63 61 46 162
CLOPIDOGREL 62 53 47 55
PHENYTOIN SODIUM EXTENDED 62 62 47 140
SANTYL 60 50 49 323
NOVOLIN 70-30 54 54 50 402
PREDNISONE 51 43 51 39
DILTIAZEM 24HR CD 51 51 51 113
VALPROIC ACID 51 28 51 261
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.